Skip to content
Home
Solution
Leadership
Investors
News
Contact
Home
Solution
Leadership
Investors
News
Contact
Pipeline
Co-formulation of FDA-approved rapid-acting insulin and glucagon
Pipeline
Anthony Schwartz
2023-05-24T09:28:12-07:00
ABV100 Co-Formulation: Pipeline
Discovery
Preclinical
Human Feasibility
IND
Phase I
Phase II
Mealtime Fixed Dose & Delivery System: Type 1 & 2 Diabetes
Fixed dose pen for major meals: Type 2 Diabetes
Vial/Cartridge for Pump Use : Type I & 2 Diabetes
Mechanism of Action
Page load link
Go to Top